924994

Aesica Formulation Development Ltd — FEI 3009421765

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 29, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nottingham (United Kingdom)